🚀 go-pugleaf

Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review  (September 24, 2011) – Revue de presse (24 septembre
2011)


Lung cancer linked to risk of stroke
People recently diagnosed with lung cancer are at higher risk of
having a stroke than those without lung tumors, suggests a large new
study from Taiwan.
By Linda Thrasybule. Reuters
http://www.reuters.com/article/2011/09/21/us-lung-cancer-stroke-idUSTRE78K71720110921

New imaging technique visualizes cancer during surgery
Ovarian cancer is one of the most frequent forms of cancer that affect
women. As tumors can initially grow unchecked in the abdomen without
causing any major symptoms, patients are usually diagnosed at an
advanced stage and have to undergo surgery plus chemotherapy. During
the operation, surgeons attempt to remove all tumor deposits as this
leads to improved patient prognosis. To do this, however, they
primarily have to rely on visual inspection and palpation - an
enormous challenge especially in the case of small tumor nests or
remaining tumor borders after the primary tumor excision.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2011-09/tum-nit091911.php

Cellular Origin of a Rare Form of Breast Cancer Identified
Identifying the cellular origins of breast cancer might lead to
earlier diagnosis and more efficient management of the disease. New
research led by Charlotte Kuperwasser of Tufts University School of
Medicine (TUSM) has determined that common forms of breast cancer
originate from breast cells known as luminal epithelial cells while
rarer forms of breast cancer, such as metaplastic carcinomas,
originate from basal epithelial cell types. The study was published
online ahead of print this week in PNAS Early Edition as part of its
breast cancer special feature.
Newswise (press release)
http://www.newswise.com/articles/cellular-origin-of-a-rare-form-of-breast-cancer-identified

In 40 Years of Cancer Research, How Far Have We Come?
It's been 40 years since President Richard Nixon signed the National
Cancer Act in 1971, the historic legislation that focused attention —
and perhaps more importantly, government funding — on the need to
research and find treatments for cancer. By Alice Park. In Time
http://healthland.time.com/2011/09/21/cancer-researchs-40th-anniversary-how-far-have-we-come/?iid=pf-main-mostpop2

NIH scientists find approach to enhance and prolong immune attack
against tumor cells
Investigators have identified a new class of human immune cells that
behave like stem cells. These cells, a subtype of T lymphocytes, which
comprise a small fraction of white blood cells, may prove more
effective than any previously reported type of T cell for treating
tumors.
National Institutes of Health (press release)
http://www.nih.gov/news/health/sep2011/nci-18.htm

Factbox: How advanced is stem cell research?
Desperate for a remedy, patients with incurable diseases are admitting
themselves into hospitals from China and India to Mexico, Russia and
Turkey for "stem cell therapies" that are backed by little or no
scientific evidence and at best only experimental.
By Tan Ee Lyn. Reuters
http://www.reuters.com/article/2011/09/21/us-factbox-idUSTRE78K18620110921

FDA OKs Bone Drug to Prevent Fracture in Certain Cancer Patients
The US Food and Drug Administration has expanded approval for the
Amgen bone-building drug Prolia (denosumab) to include prostate cancer
or breast cancer patients who are taking certain hormonal therapies.
U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/09/19/fda-oks-bone-drug-to-prevent-fracture-in-certain-cancer-patients

Death Rate Higher in Minorities With Acute Leukemia‎
Yet blacks and Hispanics are less likely to get the disease.
U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/09/22/death-rate-higher-in-minorities-with-acute-leukemia

Cancer Rises in Africa, a Continent Unequipped to Deal With it
Earlier this year, Ann Kim, a freelance journalist on a fellowship
from the International Reporting Project, went to Botswana to report
on AIDS, where the adult HIV prevalence is 24 percent, the second
highest in the world. She found AIDS, but she also found cancer.
By David J. Olson. In Huffington Post (blog)
http://www.huffingtonpost.com/david-j-olson/cancer-africa_b_967605.html

Novel technique reveals both gene number and protein expression
simultaneously
Researchers have discovered a method for simultaneously visualizing
gene number and protein expression in individual cells. The
fluorescence microscopy technique could permit a detailed analysis of
the relationship between gene status and expression of the
corresponding protein in cells and tissues, and bring a clearer
understanding of cancer and other complex diseases, according to
researchers who led the study.
EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2011-09/osum-ntr092211.php

Le cancer dû à une irradiation porterait une "signature" de son
origine‎
Comment distinguer cancers dus à une irradiation et cancers
spontanés ? Une équipe de chercheurs du Commissariat à l'énergie
atomique a découvert de premières signatures moléculaires qui
pourraient permettre de savoir si un cancer de la thyroïde est lié ou
non à l'accident de Tchernobyl. Par Annie HAUTEFEUILLE. AFP
http://www.google.com/hostednews/afp/article/ALeqM5itOFjHZXJAPMGsWWaXLhJlvIqzrw?docId=CNG.56046555f9ecb55dd1a98c39237f77be.b1

« Cancer du pressing » : première mise en examen
Un gérant de pressing utilisant du perchloroéthylène (solvant) est mis
en examen pour homicide involontaire. Une première en France.
Par Nolwenn Bouvier. Dans Rue89
http://www.rue89.com/planete89/2011/09/21/cancer-du-pressing-premiere-mise-en-examen-222890

Sanofi conserve jusqu'en 2012 l'exclusivité de l'Eloxatine sur le
marché américain
Sanofi-Aventis a annoncé lundi dans un communiqué avoir obtenu de la
justice américaine le droit de conserver jusqu'en août 2012
l'exclusivité aux Etats-Unis de la vente de l'Eloxatine, son
médicament contre le cancer colorectal.
AFP
http://www.google.com/hostednews/afp/article/ALeqM5gxV8cAwwVi6uhw76J9CWYICEfCYg?docId=CNG.3c16b0dba56e1962641116b21e41dffc.3b1

Des chercheurs identifient le système des tumeurs cérébrales
Une équipe internationale de chercheurs a découvert que le second type
de tumeur maligne cérébrale chez les enfants est l'épendymome. Ces
résultats font partie d'une étude moléculaire-génétique sur
l'épendymome du cervelet. Présentée dans la revue Cancer Cell, l'étude
révèle que d'après les anomalies de leur matériel génétique,
l'épendymome du cervelet est classifié en deux sous-groupes distincts:
l'épendymome du goupe A et l'épendymome de groupe B. Le premier
comprend des caractéristiques négatives tandis que le dernier engendre
un pronostic positif.
CORDIS Nouvelles
http://cordis.europa.eu/fetch?CALLER=FR_NEWS&ACTION=D&SESSION=&RCN=33822










Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix – InTextoResearch – Baelen  (09/2011)